Quality Management Optimizing HEDIS & STARSAnthem Blue Cross and Blue Shield | CommercialFebruary 11, 2025

Chlamydia Screening (CHL) 2025

HEDIS® is a widely used set of performance measures developed by the National Committee for Quality Assurance (NCQA). These are used to drive improvement efforts surrounding best practices.

HEDIS measure

This HEDIS measure looks at the percentage of patients 16 to 24 years old who were recommended for routine chlamydia screening, identified as sexually active, and who had at least one test for chlamydia during the measurement year.

Sexually active members are defined by either diagnosis codes, procedures, pregnancy tests, or a prescription for contraceptives.

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-075470-24-CPN74908

ATTACHMENTS: Chlamydia Screening (CHL) 2025 (pdf - 0.82mb)